Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

COVID-19 y embarazo: reporte de 15 casos

COVID-19 and pregnancy: report of 15 cases.

Ginecol Obstet Mex. 2021; 89 (10): 753-759.

https://doi.org/10.24245/gom.v89i10.5639

Jesús Martín Zárate-Moroyoqui,1 Francisca Guadalupe González-Rangel,2 Yadhira Elizeth Montes-Casillas,3 Gabriela Fimbres-García4

1 Ginecoobstetra, Hospital General de Zona 15, Instituto Mexicano del Seguro Social, Reynosa, Tamaulipas.
2 Residente de quinto año de Oncología ginecológica, Unidad Médica de Alta Especialidad, Hospital de Ginecoobstetricia, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro
Social, Guadalajara, Jalisco.
3 Uroginecóloga, Hospital General Regional 1, Instituto Mexicano del Seguro Social, Ciudad Obregón, Sonora.
4 Ginecoobstetra, Hospital General de Subzona 9, Instituto Mexicano del Seguro Social, Puerto Peñasco, Sonora.


Corrrespondencia:

Jesús Martín Zárate Moroyoqui
martin_zm@live.com.mx

Debe citarse como:

Zárate-Moroyoqui JM, González-Rangel FG, Montes-Casillas YE, Fimbres-García G. COVID-19 y embarazo: reporte de 15 casos. Ginecol Obstet Mex 2021; 89 (10): 753-759. https://doi.org/10.24245/gom.v89i10.5639

Resumen

OBJETIVO: Describir las características clínicas del embarazo, las alteraciones bioquímicas y desenlaces obstétricos de las pacientes con prueba positiva de COVID-19.

MATERIALES Y MÉTODOS: Estudio observacional, de serie de casos, analítico, retrospectivo y transversal efectuado mediante la revisión de expedientes clínicos de pacientes embarazadas y cuadro clínico confirmado (mediante PCR para SARS-CoV-2) de COVID-19.

RESULTADOS: Se estudiaron 15 casos de pacientes con prueba positiva para SARS-CoV-2. La media de edad fue de 28.67 años (DE ± 6.11); 14 de las 15 cursaban el tercer trimestre del embarazo, 11 de 15 tuvieran un cuadro leve de la enfermedad. La finalización del embarazo fue por cesárea en 12 de 15 pacientes y en las 3 restantes se requirió atención especializada por parte de Medicina crítica.

CONCLUSIONES: Las características clínicas y la severidad de la enfermedad parecen ser similares en pacientes embarazadas y no embarazadas. El principal motivo de hospitalización y finalización del embarazo fue por causa obstétrica.

PALABRAS CLAVE: COVID-19; SARS COV-2; embarazo; alteraciones bioquímicas; Obstetricia; PCR; tercer trimestre del embarazo; complicaciones del embarazo.

Abstract

OBJECTIVE: To describe the clinical characteristics of pregnancy, biochemical alterations and obstetric outcomes of patients with positive COVID-19 test.

MATERIALS AND METHODS: Observational, case series, analytical, retrospective, and cross-sectional study performed by reviewing clinical records of pregnant patients with confirmed clinical picture (by PCR for SARS-CoV-2) of COVID-19.

RESULTS: Fifteen cases of patients with positive test for SARS-CoV-2 were studied. The mean age was 28.67 years (SD ± 6.11); 14 of the 15 were in the third trimester of pregnancy, 11 of 15 had mild disease. Pregnancy was terminated by cesarean section in 12 of 15 patients and 3 of 15 required specialized care by specialists in critical care medicine.

CONCLUSIONS: The clinical features and severity of the disease appear to be similar in pregnant and non-pregnant patients. The main reason for hospitalization and termination of pregnancy was due to obstetric causes.

KEYWORDS: COVID-19; SARS CoV-2; Pregnancy; Biochemical alterations; Obstetric; PCR; Pregnancy trimester, third; Pregnancy complications.

    1. Elwood C, Raeside A, Watson H, Boucoiran I, Money D, Yudin M, et al. Committee Opinion No. 400: COVID-19 and Pregnancy [Internet]. 2021 feb. https://sogc.org/common/Uploaded%20files/Latest%20News/Committee%20Opinion%20No.%20400%20COVID-19%20and%20Pregnancy.pdf
    2. Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev 2021; 101 (1): 303-18. doi: 10.1152/physrev.00024.2020
    3. Centro Nacional de Equidad de Género y Salud Reproductiva. Lineamiento para la prevención y mitigación de COVID-19 en la atención del embarazo, parto, puerperio y de la persona recién nacida. México: Gobierno del Estado, 2020. https://www.gob.mx/cms/uploads/attachment/file/546239/Lineamiento_prevencion_y_mitigacion_de_COVID-19_en_el_embarazo_CNEGSR__1_.pdf
    4. La Cour Freiesleben N, Egerup P, Hviid KVR, Severinsen ER, Kolte AM, et al. SARS-CoV-2 in first trimester pregnancy: a cohort study. Hum Reprod 2021; 36 (1): 40-47. doi: 10.1093/humrep/deaa311
    5. D'Souza R, Ashraf R, Rowe H, Zipursky J, Clarfield L, et al. Pregnancy and COVID-19: pharmacologic considerations. Ultrasound Obstet Gynecol 2021; 57 (2): 195-203. doi: 10.1002/uog.23116
    6. World Health Organization. COVID-19 Weekly Epidemiological Update. 2021 jun. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---1-june-2021
    7. Dirección General de Epidemiologia. Lineamiento Estandarizado para la Vigilancia Epidemiológica y por Laboratorio de la Enfermedad Respiratoria Viral. Secretaria de Salud. Abril 2020. https://coronavirus.gob.mx/wp-content/uploads/2020/04/Lineamiento_de_vigilancia_epidemiologica_de_enfermedad_respiratoria-_viral.pdf
    8. Salem D, Katranji F, Bakdash T. COVID-19 infection in pregnant women: Review of maternal and fetal outcomes. Int J Gynaecol Obstet 2021; 152 (3): 291-298. doi: 10.1002/ijgo.13533
    9. Rotshenker-Olshinka K, Volodarsky-Perel A, Steiner N, Rubenfeld E, Dahan MH. COVID-19 pandemic effect on early pregnancy: are miscarriage rates altered, in asymptomatic women? Arch Gynecol Obstet 2021; 303 (3): 839-845. doi: 10.1007/s00404-020-05848-0
    10. Zhou J, Wang Y, Zhao J, Gu L, Yang C, et al. The metabolic and immunological characteristics of pregnant women with COVID-19 and their neonates. Eur J Clin Microbiol Infect Dis 2021; 40 (3): 565-74. doi: 10.1007/s10096-020-04033-0
    11. Royal College of Obstetricians & Gynaecologists. Coronavirus (COVID-19) Infection in Pregnancy. Information for healthcare professionals. Versión 13. 2021 feb. https://www.rcog.org.uk/globalassets/documents/guidelines/2021-02-19-coronavirus-covid-19-infection-in-pregnancy-v13.pdf
    12. Poon LC, Yang H, Dumont S, Lee JCS, Copel JA, Danneels L, et al. ISUOG Interim Guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol 2020; 55: 848-62 https://doi.org/10.1002/uog.22061
    13. Du M, Yang J, Han N, Liu M, Liu J. Association between the COVID-19 pandemic and the risk for adverse pregnancy outcomes: a cohort study. BMJ Open 2021; 11 (2): e047900. doi: 10.1136/bmjopen-2020-047900
    14. Moore KM, Suthar MS. Comprehensive analysis of COVID-19 during pregnancy. Biochem Biophys Res Commun 2021; 538: 180-86. doi: 10.1016/j.bbrc.2020.12.064
    15. Centre de Medicina Fetal i Neonatal de Barcelona. Protocolo: coronavirus (Covid-19) y gestación (v8 - 30/05/2020). España: Clinic Barcelona, 2020.https://medicinafetalbarcelona.org/protocolos/es/patologia-materna-obstetrica/covid19-embarazo.pdf
    16. Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol 2020; 56: 15-27 https://doi.org/10.1002/uog.22088
    17. MS THM, Vaught J, and the SMFM COVID-19 Task Force. Management Considerations for Pregnant Patients With COVID-19. 2021 feb. https://s3.amazonaws.com/cdn.smfm.org/media/2734/SMFM_COVID_Management_of_COVID_pos_preg_patients_2-2-21_(final).pdf
    18. National Institutes of Health. COVID-19 Treatment Guidelines Panel, coronavirus Disease 2019 (COVID-19) treatment guidelines. NIH; 2020. https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
    19. Di Toro F, Gjoka M, Di Lorenzo G, De Santo D, De Seta F, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect 2021; 27 (1): 36-46. doi: 10.1016/j.cmi.2020.10.007
    20. Cavalcante MB, Cavalcante CTMB, Sarno M, Barini R, Kwak-Kim J. Maternal immune responses and obstetrical outcomes of pregnant women with COVID-19 and possible health risks of offspring. J Reprod Immunol 2021; 143: 103250. doi: 10.1016/j.jri.2020.103250
    21. Oshay RR, Chen MYC, Fields BKK, Demirjian NL, Lee RS, Mosallaei D, Gholamrezanezhad A. COVID-19 in pregnancy: a systematic review of chest CT findings and associated clinical features in 427 patients. Clin Imaging 2021; 75:75-82. doi: 10.1016/j.clinimag.2021.01.004
    22. Matar R, Alrahmani L, Monzer N, Debiane LG, Berbari E, Fares J, Fitzpatrick F, Murad MH. Clinical Presentation and Outcomes of Pregnant Women with Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Clin Infect Dis 2021; 72 (3): 521-33. doi: 10.1093/cid/ciaa828
    23. Dirección General de Epidemiologia. Recomendaciones para el tratamiento de la infección por SARS-CoV-2, agente causal de COVID-19. México: Secretaria de Salud; 2020. https://coronavirus.gob.mx/wp-content/uploads/2020/07/Recomendaciones_para_tratamiento_SARS-CoV2.pdf
    24. Barrantes JH, Ortoleva J, O'Neil ER, Suarez EE, Beth Larson S, et al. Successful Treatment of Pregnant and Postpartum Women with Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation. ASAIO J 2021; 67 (2): 132-36. doi: 10.1097/MAT.0000000000001357
    25. Lopian M, Kashani-Ligumsky L, Czeiger S, Cohen R, Schindler Y, et al. Safety of vaginal delivery in women infected with COVID-19. Pediatr Neonatol 2021; 62 (1): 90-96. doi: 10.1016/j.pedneo.2020.10.010
    26. Wang CL, Liu YY, Wu CH, Wang CY, Wang CH, Long CY. Impact of COVID-19 on Pregnancy. Int J Med Sci 2021; 18 (3): 763-67. doi: 10.7150/ijms.49923
    27. Halscott T, Vaught J, Miller E. Management considerations for pregnant patients with COVID-19. EEUU: Society for Maternal-Fetal Medicine, 2020. https://s3.amazonaws.com/cdn.smfm.org/media/2415/SMFM_COVID_Management_of_COVID_pos_preg_patients_7-2-20.PDF_.pdf
    28. Benhamou D, Keita H, Ducloy-Bouthors AS; Obstetric Anaesthesia and Critical Care Club Working Group. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients. Anaesth Crit Care Pain Med 2020; 39 (3): 351-53. doi: 10.1016/j.accpm.2020.05.003
    29. Guasch E, Brogly N, Manrique S. Practical recommendations in the obstetrical patient with a COVID-19 infection. Rev Esp Anestesiol Reanim 2020; 67 (8): 438-45. doi: 10.1016/j.redar.2020.06.009

Comentarios